Gene expression-based diagnostics for molecular cancer classification of difficult to diagnose tumors

作者: Catherine A Schnabel , Mark G Erlander

DOI: 10.1517/17530059.2012.704363

关键词: CancerClinical PracticeDirect evaluationCancer classificationCancer biomarkersGene expression profilingMolecular diagnosticsBioinformaticsMedicineSite of origin

摘要: Introduction: Standardized methods for accurate tumor classification are of critical importance cancer diagnosis and treatment, particularly in diagnostically-challenging cases where site-directed therapies an option. Molecular diagnostics classification, subclassification site origin determination based on advances gene expression profiling have translated into clinical practice as complementary approaches to clinicopathological evaluations. Areas covered: In this review, the foundational science expression-based technical considerations translation, overview molecular signatures that available use will be discussed. Proposed also described further integration tests diagnostic paradigm using a tissue-based strategy key component direct evaluation. Expert opinion: Increasing evidence improve...

参考文章(98)
Maureen Cronin, Mylan Pho, Debjani Dutta, James C. Stephans, Steven Shak, Michael C. Kiefer, Jose M. Esteban, Joffre B. Baker, Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay. American Journal of Pathology. ,vol. 164, pp. 35- 42 ,(2004) , 10.1016/S0002-9440(10)63093-3
Adam Foye, Phillip G. Febbo, Cancer gene profiling in prostate cancer. Methods of Molecular Biology. ,vol. 576, pp. 293- 326 ,(2009) , 10.1007/978-1-59745-545-9_15
Ajay Joseph, Vincent J. Gnanapragasam, Laser-capture microdissection and transcriptional profiling in archival FFPE tissue in prostate cancer. Methods of Molecular Biology. ,vol. 755, pp. 291- 300 ,(2011) , 10.1007/978-1-61779-163-5_24
Vasily Sharov, Ka Kwong, Bryan Frank, Emily Chen, Jeremy Hasseman, Renee Gaspard, Yan Yu, Ivana Yang, John Quackenbush, The limits of log-ratios BMC Biotechnology. ,vol. 4, pp. 3- 3 ,(2004) , 10.1186/1472-6750-4-3
Charles Swanton, Carlos Caldas, None, From genomic landscapes to personalized cancer management-is there a roadmap? Annals of the New York Academy of Sciences. ,vol. 1210, pp. 34- 44 ,(2010) , 10.1111/J.1749-6632.2010.05776.X
J J Rusthoven, I C Quirt, N A Iscoe, P B McCulloch, K W James, R C Lohmann, J Jensen, S Burdette-Radoux, A J Bodurtha, H K Silver, S Verma, G R Armitage, B Zee, K Bennett, Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology. ,vol. 14, pp. 2083- 2090 ,(1996) , 10.1200/JCO.1996.14.7.2083
Hai Long XIE, Zhi Yu LI, Run Liang GAN, Xiao Jie LI, Qing Li ZHANG, Mei HUI, Xiu Tian ZHOU, Differential gene and protein expression in primary gastric carcinomas and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Journal of Digestive Diseases. ,vol. 11, pp. 167- 175 ,(2010) , 10.1111/J.1751-2980.2010.00432.X
S. Kopetz, J. Desai, E. Chan, J. R. Hecht, P. J. O'Dwyer, R. J. Lee, K. B. Nolop, L. Saltz, PLX4032 in metastatic colorectal cancer patients with mutant BRAF tumors. Journal of Clinical Oncology. ,vol. 28, pp. 3534- 3534 ,(2010) , 10.1200/JCO.2010.28.15_SUPPL.3534
J L Abbruzzese, M C Abbruzzese, R Lenzi, K R Hess, M N Raber, Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. Journal of Clinical Oncology. ,vol. 13, pp. 2094- 2103 ,(1995) , 10.1200/JCO.1995.13.8.2094
Lee M. Krug, Vincent A. Miller, Jyoti Patel, John Crapanzano, Christopher G. Azzoli, Jorge Gomez, Mark G. Kris, Robert T. Heelan, Barbara Pizzo, Leslie Tyson, Christine Sheehan, Jeffrey S. Ross, Ennapadam Venkatraman, Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma Cancer. ,vol. 104, pp. 2149- 2155 ,(2005) , 10.1002/CNCR.21428